Table 4.
Alternative scenario of switch options on the introduction of PCV.
| Scenario | Year | Vaccine | Presentation | Price |
|---|---|---|---|---|
| Base-case | 2019–2023 | PCV13 | 1 dose/vial | Contract and Gavi-AMC price * |
| 2024 | PCV13 | 4 doses/vial | Gavi-AMC price | |
| Multi-dose PCV13 | 2019–2020 | PCV13 | 1 dose/vial | Contract price |
| 2021–2024 | PCV13 | 4 doses/vial | Gavi-AMC price | |
| Multi-dose PCV10 A | 2019–2020 | PCV13 | 1 dose/vial | Contract price |
| 2021–2024 | PCV10 A | 4 doses/vial | Gavi-AMC price | |
| Multi-dose PCV10 B | 2019–2020 | PCV13 | 1 dose/vial | Contract price |
| 2021–2024 | PCV10 B | 5 doses/vial | Gavi-AMC price |
* Government contract price: 2019–2020; Gavi-AMC price: 2021–2024.